Excessive Bleeding After Cardiac Surgery in Adults: Reasons and Management

Excessive Bleeding After Cardiac Surgery in Adults: Reasons and Management Postoperative bleeding is a concern for all patients undergoing cardiac surgery. In patients exposed to cardiopulmonary bypass, bleeding following surgery is excessive in up to twelve percent of patients in whom subsequent re-exploration is required. Several studies have evaluated main reasons, prevention of excessive postoperative bleeding and impact of patients outcomes. This article contains a literature review on excessive bleeding and re-exploration following cardiac surgery, main surgical and medical sources, prevention and management of bleeding.

[1]  F. Chung,et al.  Topical application of antifibrinolytic drugs for on-pump cardiac surgery: a systematic review and meta-analysis , 2009, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[2]  G. Gravlee.  Cardiopulmonary Bypass Duration Is an Independent Predictor of Morbidity and Mortality After Cardiac Surgery , 2009 .

[3]  M. Ranucci,et al.  Surgical reexploration after cardiac operations: why a worse outcome? , 2008, The Annals of thoracic surgery.

[4]  W. Beattie,et al.  Comprehensive Canadian Review of the Off-Label Use of Recombinant Activated Factor VII in Cardiac Surgery , 2008, Circulation.

[5]  R. Benetis,et al.  Influence of early re-infusion of autologous shed mediastinal blood on clinical outcome after cardiac surgery , 2007, Perfusion.

[6]  R. Wolfe,et al.  Monitoring the rate of re-exploration for excessive bleeding after cardiac surgery in adults , 2007, Quality and Safety in Health Care.

[7]  R. McManus,et al.  Coagulopathy After Cardiac Surgery May Be Influenced by a Functional Plasminogen Activator Inhibitor Polymorphism , 2007, Anesthesia and analgesia.

[8]  A. Vuylsteke,et al.  Delayed re-exploration for bleeding after coronary artery bypass surgery results in adverse outcomes. , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[9]  B. Biočina,et al.  Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study. , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[10]  H. Riess,et al.  Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation. , 2007, Thrombosis research.

[11]  Keyvan Karkouti,et al.  Prediction of massive blood transfusion in cardiac surgery , 2006, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[12]  K. M. Abdullah,et al.  Effect of topical tranexamic acid in open heart surgery , 2006, European journal of anaesthesiology.

[13]  I. C. Tudor,et al.  The risk associated with aprotinin in cardiac surgery. , 2006, The New England journal of medicine.

[14]  S. Kinduris,et al.  [Bleeding after cardiac surgery: risk factors, frequency, and outcomes]. , 2006, Medicina.

[15]  M. Borger,et al.  Low hematocrit during cardiopulmonary bypass is associated with increased risk of perioperative stroke in cardiac surgery. , 2005, The Annals of thoracic surgery.

[16]  A. Gonzalez,et al.  Hemodilution and surgical hemostasis contribute significantly to transfusion requirements in patients undergoing coronary artery bypass. , 2005, The Journal of thoracic and cardiovascular surgery.

[17]  W. Chandler.  Effects of hemodilution, blood loss, and consumption on hemostatic factor levels during cardiopulmonary bypass. , 2005, Journal of cardiothoracic and vascular anesthesia.

[18]  W. Vaughn,et al.  Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting. , 2004, The Journal of thoracic and cardiovascular surgery.

[19]  J. Andreasen,et al.  Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[20]  S. Karthik,et al.  Reexploration for bleeding after coronary artery bypass surgery: risk factors, outcomes, and the effect of time delay. , 2004, The Annals of thoracic surgery.

[21]  V. Casati.  Tranexamic acid and coronary surgery. , 2004, Anesthesia and Analgesia.

[22]  E. Øvrum,et al.  Quality of intraoperative autologous blood withdrawal used for retransfusion after cardiopulmonary bypass. , 2003, The Annals of thoracic surgery.

[23]  B. Medalion,et al.  Tranexamic acid reduces bleeding and the need for blood transfusion in primary myocardial revascularization. , 2002, The Annals of thoracic surgery.

[24]  H. Hirose,et al.  Re-exploration for bleeding after coronary artery bypass grafting: what is the acceptable range of re-exploration rate? , 2002, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[25]  S. Karthikeyan,et al.  Retrograde autologous priming of the cardiopulmonary bypass circuit reduces blood transfusion after coronary artery surgery. , 2002, The Annals of thoracic surgery.

[26]  J. Dunne,et al.  Perioperative anemia: an independent risk factor for infection, mortality, and resource utilization in surgery. , 2002, The Journal of surgical research.

[27]  A. Spotnitz,et al.  Re-exploration for hemorrhage following open heart surgery differentiation on the causes of bleeding and the impact on patient outcomes. , 2001, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[28]  C. Tribble,et al.  Cardiac reoperation in the intensive care unit. , 2001, The Annals of thoracic surgery.

[29]  M. Goldman.  Pharmacological strategies to decrease excessive blood loss in cardiac surgery: A meta-analysis of clinically relevant endpoints , 2000 .

[30]  F. Cavaliere,et al.  Topical use of tranexamic acid in coronary artery bypass operations: a double-blind, prospective, randomized, placebo-controlled study. , 2000, The Journal of thoracic and cardiovascular surgery.

[31]  M. Prins,et al.  Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints , 1999, The Lancet.

[32]  O. Alfieri,et al.  Hemostatic effects of aprotinin, tranexamic acid and ϵ-aminocaproic acid in primary cardiac surgery , 1999 .

[33]  O. Alfieri,et al.  Hemostatic effects of aprotinin, tranexamic acid and epsilon-aminocaproic acid in primary cardiac surgery. , 1999, The Annals of thoracic surgery.

[34]  J. Rich,et al.  The efficacy and safety of aprotinin use in cardiac surgery. , 1998, The Annals of thoracic surgery.

[35]  G. Tzelepis,et al.  Unexpected cardiac arrest after cardiac surgery: incidence, predisposing causes, and outcome of open chest cardiopulmonary resuscitation. , 1998, Chest.

[36]  A. Laupacis,et al.  Drugs to Minimize Perioperative Blood Loss in Cardiac Surgery: Meta-Analyses Using Perioperative Blood Transfusion As the Outcome , 1997, Anesthesia and analgesia.

[37]  G. Nuttall,et al.  Does the Platelet-Activated Clotting Test (HemoSTATUS[registered sign]) Predict Blood Loss and Platelet Dysfunction Associated with Cardiopulmonary Bypass? , 1997, Anesthesia and analgesia.

[38]  A. Montoya,et al.  Management of postoperative heparin rebound following cardiopulmonary bypass. , 1981, The Journal of thoracic and cardiovascular surgery.

[39]  G. Parulkar,et al.  Heparin rebound--a cause of bleeding following open heart surgery. , 1979, Journal of postgraduate medicine.